274 related articles for article (PubMed ID: 30195774)
21. Exploring the prognostic significance of iron death‑related lncRNAs in colorectal cancer: A systematic review and meta‑analysis.
Hang X; Du Z; Song J
Oncol Lett; 2024 Jun; 27(6):284. PubMed ID: 38736739
[TBL] [Abstract][Full Text] [Related]
22. lncRNAs as potential molecular biomarkers in the clinicopathology and prognosis of cholangiocarcinoma: a systematic review and meta-analysis.
Dai K; Quan J; Yan F; Jin X; Pan X; Song X; Zhang S; Ren Q; Liu J; Liu X
Onco Targets Ther; 2019; 12():1905-1915. PubMed ID: 30881042
[TBL] [Abstract][Full Text] [Related]
23. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
Zhu W; Liu H; Wang X; Lu J; Yang W
Pathol Res Pract; 2019 Jun; 215(6):152429. PubMed ID: 31064722
[TBL] [Abstract][Full Text] [Related]
26. LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study.
Zhang W; Wang Y; Deng S; Zhu YC
Transl Cancer Res; 2023 Nov; 12(11):3156-3165. PubMed ID: 38130297
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and Clinicopathological Significance of lncRNA MVIH in Cancer Patients.
Zhang Y; Lin S; Yang X; Zhang X
J Cancer; 2019; 10(6):1503-1510. PubMed ID: 31031860
[No Abstract] [Full Text] [Related]
28. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
29. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Liu X; Chen L; Xu Z; Shao J
Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
[TBL] [Abstract][Full Text] [Related]
30. Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis.
Yu G; Zhang W; Zhu L; Xia L
Onco Targets Ther; 2018; 11():1491-1499. PubMed ID: 29588602
[TBL] [Abstract][Full Text] [Related]
31. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis.
Serghiou S; Kyriakopoulou A; Ioannidis JP
Mol Cancer; 2016 Jun; 15(1):50. PubMed ID: 27352941
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of lncRNAs in lung carcinoma: a meta-analysis.
Fan F; Zhu Z; Gao C; Liu Y; Wang B; Wang Z; Feng J
Oncotarget; 2017 Oct; 8(47):83292-83305. PubMed ID: 29137343
[TBL] [Abstract][Full Text] [Related]
34. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of Sox2 expression in patients with breast cancer: a meta-analysis.
Zheng Y; Qin B; Li F; Xu S; Wang S; Li L
Int J Clin Exp Med; 2015; 8(12):22382-92. PubMed ID: 26885218
[TBL] [Abstract][Full Text] [Related]
36. The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis.
Zhou S; He Y; Yang S; Hu J; Zhang Q; Chen W; Xu H; Zhang H; Zhong S; Zhao J; Tang J
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30217944
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.
Xu F; Zhang C; Cui J; Liu J; Li J; Jiang H
Medicine (Baltimore); 2017 Sep; 96(36):e8000. PubMed ID: 28885360
[TBL] [Abstract][Full Text] [Related]
38. lncRNA PVT1 in cancer: A review and meta-analysis.
Lu D; Luo P; Wang Q; Ye Y; Wang B
Clin Chim Acta; 2017 Nov; 474():1-7. PubMed ID: 28866116
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan.
Almasri NM; Al Hamad M
Breast Cancer Res; 2005; 7(5):R598-604. PubMed ID: 16168103
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
